Medicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

On April 14, 2026 Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, reported that Dr. Fahar Merchant, President and CEO of Medicenna, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference, taking place in Toronto on April 21-22, 2026.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

During this investor presentation, the Company will provide a corporate update as well as latest MDNA113 preclinical data from the 2026 Annual Meeting of the American Association for Cancer Research (AACR) (Free AACR Whitepaper). More details are as follows:

Date: Tuesday, April 21, 2026
Time: 3:00 p.m. Eastern Time
Location: Metro Toronto Convention Centre, Toronto
Webcast Link: https://event.summitcast.com/view/7Mc8ivebFGUgA8YD45rSGK/UpbJ5d5vehkPikKiwCUsv6

Webcast and replay information for this event will also be available on the Investor Relations section of Medicenna’s website at ir.medicenna.com. The replay will be available for 90 days.

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from premier Canadian publicly traded and private companies through presentations and private meetings. For more information, please visit: bloomburton.com/conference.

(Press release, Medicenna Therapeutics, APR 14, 2026, View Source [SID1234664359])